Financial reports
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
16 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Unicycive Announces $50 Million Private Placement
14 Mar 24
8-K
Entry into a Material Definitive Agreement
14 Mar 24
8-K
Other Events
21 Feb 24
8-K
Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update
14 Nov 23
8-K
Other Events
23 Oct 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
25 Sep 23
8-K
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD
6 Sep 23
8-K
Changes in Registrant's Certifying Accountant
31 Aug 23
8-K
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
14 Aug 23
8-K
Changes in Registrant's Certifying Accountant
31 Jul 23
Registration and prospectus
D
$50.00 mm in equity / options / securities to be acquired, sold $50.00 mm, 25 investors
20 Mar 24
S-8
Registration of securities for employees
8 Dec 23
S-3
Shelf registration
12 Jul 23
D
$30.19 mm in equity / options / securities to be acquired, sold $30.19 mm, 20 investors
13 Mar 23
S-3
Shelf registration
15 Aug 22
S-8
Registration of securities for employees
13 Sep 21
424B4
Prospectus supplement with pricing info
14 Jul 21
S-1/A
IPO registration (amended)
12 Jul 21
S-1/A
IPO registration (amended)
12 Jul 21
8-A12B
Registration of securities on exchange
6 Jul 21
Proxies
PRE 14A
Preliminary proxy
16 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Jun 23
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
28 Apr 23
PRE 14A
Preliminary proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
19 Apr 22
DEF 14A
Definitive proxy
19 Apr 22
Other
EFFECT
Notice of effectiveness
4 Aug 23
CORRESP
Correspondence with SEC
1 Aug 23
UPLOAD
Letter from SEC
19 Jul 23
EFFECT
Notice of effectiveness
25 Aug 22
CORRESP
Correspondence with SEC
22 Aug 22
UPLOAD
Letter from SEC
22 Aug 22
SEC STAFF
SEC staff action: Order
21 Jul 21
EFFECT
Notice of effectiveness
13 Jul 21
CORRESP
Correspondence with SEC
8 Jul 21
CORRESP
Correspondence with SEC
8 Jul 21
Ownership
4
John Townsend
17 Apr 24
4
Douglas Jermasek
17 Apr 24
4
Pramod Gupta
17 Apr 24
4
Shalabh K. Gupta
17 Apr 24
SC 13G/A
RA CAPITAL MANAGEMENT, L.P.
14 Feb 24
SC 13G/A
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
SC 13G
Nantahala Capital Partners Limited Partnership
5 Feb 24
SC 13G
Logos Global Management LP
22 Jan 24
4
Sandeep Laumas
7 Sep 23